Dynamic longitudinal exposome trajectories in cardiovascular and metabolic non-communicable diseases
Acronym
LONGITOOLS
Description of the granted funding
Environmental factors, including air and noise pollution, and the built environment, are typically associated with cardiovascular and metabolic non-communicable diseases (NCDs), e.g. obesity, type 2 diabetes, heart diseases and atherosclerosis. The extent to which these exposures may cause their attributed health effects (via molecular mediation) directly or indirectly as a result of associations to an individual’s psychosocial context is largely unknown. NCDs arise from a lifelong process influencing anthropometric, glycaemic, cardiac and lipid-related health trajectories. Risks may start as early as during the fetal period and are modified during sensitive periods in childhood, adolescence and adulthood. Despite this, research has not focused enough on the life-course characterisation of the exposome and the application of this to health and disease. In 5 years, LONGITOOLS, a partnership of 15 academic groups and 3 small companies will harness a catalogue of birth cohorts, longitudinal data, registers and biobanks. We will characterise coincident longitudinal trajectories of exposure and cardiometabolic health combining the study of longitudinal effects and internal responses. The latter will include measures of DNA methylation, RNA expression and read outs of metabolic pathways. LONGITOOLS will implement this longitudinal approach in 11 work packages designed to generate a catalogue of FAIR data and a novel analytical toolbox. Evidence-based life-course causal models will estimate how clinical and policy interventions may sustainably affect the health and economic burden of NCDs. A key objective will be to generate evidence-based predictions which can ultimately translate into innovative healthcare applications (apps) and policy options. LONGITOOLS will also allow researchers and policy makers to generate new knowledge - identifying the likely causal (direct and indirect) mechanisms through which exposures to man-made environmental factors affect the risk of NCDs. LONGITOOLS is one of the nine projects composing the European Human Exposome Network.
Show moreStarting year
2020
End year
2025
Granted funding
UNIVERSITY COLLEGE LONDON (UK)
729 781.25 €
Participant
CYNEXO SRL (IT)
372 955 €
Participant
STICHTING VUMC (NL)
552 321.25 €
Participant
Academisch Medisch Centrum bij de Universiteit van Amsterdam (NL)
552 321.25 €
Participant
NCC OPERATIONS LIMITED (UK)
808 992.5 €
Participant
AB.ACUS SRL (IT)
574 125 €
Participant
BETA TECHNOLOGY LTD (UK)
647 870 €
Participant
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA (IT)
555 125 €
Participant
ACADEMISCH ZIEKENHUIS GRONINGEN (NL)
600 625 €
Participant
UNIVERSITETET I OSLO (NO)
500 942.5 €
Participant
CHALMERS TEKNISKA HOEGSKOLA AB (SE)
427 941.25 €
Participant
UNIVERSITY OF SURREY (UK)
682 347.5 €
Participant
UNIVERSITEIT UTRECHT (NL)
524 257.5 €
Participant
UNIVERSITAT DE BARCELONA (ES)
716 250 €
Participant
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (NL)
896 160 €
Participant
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (UK)
796 910 €
Participant
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR)
451 375 €
Participant
Amount granted
11 997 449 €
Funder
European Union
Funding instrument
Research and Innovation action
Framework programme
Horizon 2020 Framework Programme
Call
Programme part
Health (5290 Preventing disease (5295 )
Topic
The Human Exposome Project: a toolbox for assessing and addressing the impact of environment on health (SC1-BHC-28-2019Call ID
H2020-SC1-2019-Single-Stage-RTD Other information
Funding decision number
874739
Identified topics
cardiovascular diseases